Posterity of nanoscience as lipid nanosystems for Alzheimer's disease regression
Materials Today Bio · 2023-08 · 21 · 100701
DOI: 10.1016/j.mtbio.2023.100701 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Materials Today Bio, 2023-08. Verfasst von Shaikh Sheeran Naser und 13 weiteren Autor:innen. Beteiligte Einrichtung: KIIT School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT-DU), Bhubaneswar 751024, Odisha, India. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 181 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kalinga Institute of Industrial Technology.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) is a type of dementia that affects a vast number of people around the world, causing a great deal of misery and death. Evidence reveals a relationship between the presence of soluble Aβ peptide aggregates and the severity of dementia in Alzheimer's patients. The BBB (Blood Brain Barrier) is a key problem in Alzheimer's disease because it prevents therapeutics from reaching the desired places. To address the issue, lipid nanosystems have been employed to deliver therapeutic chemicals for anti-AD therapy in a precise and targeted manner. The applicability and clinical significance of lipid nanosystems to deliver therapeutic chemicals (Galantamine, Nicotinamide, Quercetin, Resveratrol, Curcumin, HUPA, Rapamycin, and Ibuprofen) for anti-AD therapy will be discussed in this review. Furthermore, the clinical implications of the aforementioned therapeutic compounds for anti-AD treatment have been examined. Thus, this review will pave the way for researchers to fashion therodiagnostics approaches based on nanomedicine to overcome the problems of delivering therapeutic molecules across the blood brain barrier (BBB).
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- KIIT School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT-DU), Bhubaneswar 751024, Odisha, India.
- Institute of Advanced Materials, IAAM, Gammalkilsvägen 18, 59053 Ulrika, Sweden.
- Amity Institute of Biotechnology, Amity University Jharkhand, Ranchi, Jharkhand 834001, India.
- School of Biology, Indian Institute of Science Education and Research, Thiruvananthapuram, Kerala 695551, India.
- Mads Clausen Institute, NanoSYD, University of Southern Denmark, Alison 2, 6400 Sønderborg, Denmark.
- Department of Physics and Astronomy, Uppsala University, Box 516, SE-75120 Uppsala, Sweden.
Förderung
- Kalinga Institute of Industrial Technology
Zitieren
APA
Naser, S. S., Singh, D., Preetam, S., Kishore, S., Kumar, L., Nandi, A., Simnani, F. Z., Choudhury, A., Sinha, A., Mishra, Y. K., Suar, M., Panda, P. K., Malik, S., & Verma, S. K. (2023). Posterity of nanoscience as lipid nanosystems for Alzheimer's disease regression. Materials Today Bio, 21, 100701. https://doi.org/10.1016/j.mtbio.2023.100701
Vancouver
Naser SS, Singh D, Preetam S, Kishore S, Kumar L, Nandi A, et al. Posterity of nanoscience as lipid nanosystems for Alzheimer's disease regression. Materials Today Bio. 2023;21:100701. doi:10.1016/j.mtbio.2023.100701
BibTeX
@article{Naser2023,
author = {Naser, Shaikh Sheeran and Singh, Dibyangshee and Preetam, Subham and Kishore, Shristi and Kumar, Lamha and Nandi, Aditya and Simnani, Faizan Zarreen and Choudhury, Anmol and Sinha, Adrija and Mishra, Yogendra Kumar and Suar, Mrutyunjay and Panda, Pritam Kumar and Malik, Sumira and Verma, Suresh K},
title = {Posterity of nanoscience as lipid nanosystems for Alzheimer's disease regression},
journal = {Materials Today Bio},
year = {2023},
volume = {21},
pages = {100701},
doi = {10.1016/j.mtbio.2023.100701}
}
EUVIMED